Ariel Pharmaceuticals focuses on acute clinical indications where there are unmet medical needs and hard clinical endpoints that can be demonstrated in relatively short clinical trials. We have an experienced drug development team with core competencies in preclinical assessment, global clinical development, manufacturing and commercialization. To further leverage our own in-house development programs and build a well-balanced portfolio of products, we seek to acquire or partner new product opportunities.
We are interested in quality development candidates from Phase I – III in acute clinical indications.
If you would like additional information on partnering with us, or to discuss a compound currently in clinical development, please contact us via email at bizdev@arielpharma.com.